186 related articles for article (PubMed ID: 35507150)
21. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
Jayaraman VK; Thomas M
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26887886
[TBL] [Abstract][Full Text] [Related]
22. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
23. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
24. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
[TBL] [Abstract][Full Text] [Related]
25. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
[TBL] [Abstract][Full Text] [Related]
27. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
[TBL] [Abstract][Full Text] [Related]
28. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
[TBL] [Abstract][Full Text] [Related]
29. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
30. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.
Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV
Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience.
Alhasan KA; Alherbish A; Osman A; Kari JA; Almojalli H
Transplant Proc; 2019 Mar; 51(2):517-521. PubMed ID: 30879580
[TBL] [Abstract][Full Text] [Related]
32. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.
Dado D; Parikh S; Ayoub I; Rovin B; Nadasdy T; Hebert L
Clin Nephrol; 2018 May; 89(5):376-380. PubMed ID: 29249233
[TBL] [Abstract][Full Text] [Related]
33. Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis.
Hamroun A; Gibier JB; Maanaoui M; Lionet A; Gnemmi V; Bouyé S; Fantoni JC; Averland B; Antoine C; Lenain R; Hazzan M; Provôt F
Am J Kidney Dis; 2021 Dec; 78(6):897-901. PubMed ID: 34118304
[TBL] [Abstract][Full Text] [Related]
34. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
Abuzeineh M; Aala A; Alasfar S; Alachkar N
BMC Nephrol; 2020 Jul; 21(1):253. PubMed ID: 32615995
[TBL] [Abstract][Full Text] [Related]
37. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
[TBL] [Abstract][Full Text] [Related]
38. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
39. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
Alachkar N; Wei C; Arend LJ; Jackson AM; Racusen LC; Fornoni A; Burke G; Rabb H; Kakkad K; Reiser J; Estrella MM
Transplantation; 2013 Oct; 96(7):649-56. PubMed ID: 23842190
[TBL] [Abstract][Full Text] [Related]
40. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
Torres VE; Velosa JA; Holley KE; Frohnert PP; Zincke H; Sterioff S
Mayo Clin Proc; 1984 Mar; 59(3):146-52. PubMed ID: 6369011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
